Trial
NCT00668772
Tiotropium/Salmeterol Inhalation Powder in COPD
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Boehringer Ingelheim
Collaborators
—
Condition
Pulmonary Disease, Chronic Obstructive
Intervention
Tiotropium/Salmeterol
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-07